Cita APA

Traer, E., Javidi-Sharifi, N., Agarwal, A., Dunlap, J., English, I., Martinez, J., . . . Druker, B. J. (2014). Ponatinib overcomes FGF2-mediated resistance in CML patients without kinase domain mutations. American Society of Hematology.

Citación estilo Chicago

Traer, Elie, Nathalie Javidi-Sharifi, Anupriya Agarwal, Jennifer Dunlap, Isabel English, Jacqueline Martinez, Jeffrey W. Tyner, Melissa Wong, y Brian J. Druker. Ponatinib Overcomes FGF2-mediated Resistance in CML Patients Without Kinase Domain Mutations. American Society of Hematology, 2014.

Cita MLA

Traer, Elie, et al. Ponatinib Overcomes FGF2-mediated Resistance in CML Patients Without Kinase Domain Mutations. American Society of Hematology, 2014.